Novo Stock Rises, Hims & Hers Tanks. This Could Shift the Weight-Loss Copycat Battle.

Group 1 - Shares in the Danish drugmaker have significantly declined this week due to a weak sales outlook [1] - The decline is further exacerbated by the launch of a Wegovy knockoff [1]